2 purchases reported after at least 12 months of silence — most recent on 05 Dec 2014.
Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| ACCURAY INC | 162,181 | reported | 30 Nov 2017 | tx 15+248,281−29,305 |
| HERON THERAPEUTICS, INC. /DE/ | 69,544 | reported | 11 Aug 2006 | tx 10+39,223 |
| VERTEX PHARMACEUTICALS INC / MA | 11,250 | reported | 09 Mar 2012 | tx 9+115,250−77,500 |
| Pacira BioSciences, Inc. | 2,714 | reported | 14 Jun 2017 | tx 9+40,179 |
| CEPHALON INC |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 17 Aug 2018 | SALE | NEKTAR THERAPEUTICS | 15,000 | 59.62 USD | anomaly |
| 17 Aug 2018 | EXERCISE | NEKTAR THERAPEUTICS | 15,000 | 14.26 USD | |
| 21 Aug 2018 | SALE | NEKTAR THERAPEUTICS | 15,000 | 60.30 USD | anomaly |
| 21 Aug 2018 | EXERCISE | NEKTAR THERAPEUTICS | 15,000 | 14.26 USD |
| 0 |
| reported |
| 14 Oct 2011 |
| tx 16+80,000−105,000 |
| CELL GENESYS INC | 0 | reported | 14 Oct 2009 | tx 12+38,000−68,000 |
| NEKTAR THERAPEUTICS | 0 | reported | 21 Aug 2018 | tx 34+442,000−154,250 |
| APPLERA CORP | 0 | reported | 21 Nov 2008 | tx 1632+1,285,646−2,718,744.26 |
| 21 Aug 2018 | EXERCISE | NEKTAR THERAPEUTICS | 15,000 | 14.26 USD | deriv |
| 17 Aug 2018 | EXERCISE | NEKTAR THERAPEUTICS | 15,000 | 14.26 USD | deriv |
| 13 Aug 2018 | SALE | NEKTAR THERAPEUTICS | 17,125 | 61.04 USD | anomaly |
| 14 Aug 2018 | SALE | NEKTAR THERAPEUTICS | 17,125 | 60.15 USD | anomaly |
| 04 Jan 2018 | EXERCISE | NEKTAR THERAPEUTICS | 33,750 | 11.97 USD |
| 04 Jan 2018 | EXERCISE | NEKTAR THERAPEUTICS | 11,250 | 0.00 USD | deriv |
| 04 Jan 2018 | EXERCISE | NEKTAR THERAPEUTICS | 22,500 | 0.00 USD | deriv |
| 30 Nov 2017 | GRANT_AWARD | ACCURAY INC | 29,126 | 0.00 USD |
| 17 Nov 2017 | TAX_WITHHOLDING | ACCURAY INC | 9,505 | 4.80 USD |
| 19 Sept 2017 | GRANT_AWARD | NEKTAR THERAPEUTICS | 9,000 | 0.00 USD |
| 19 Sept 2017 | GRANT_AWARD | NEKTAR THERAPEUTICS | 22,500 | 0.00 USD | deriv |
| 14 Jun 2017 | GRANT_AWARD | Pacira BioSciences, Inc. | 1,357 | 0.00 USD |
| 14 Jun 2017 | GRANT_AWARD | Pacira BioSciences, Inc. | 2,714 | 0.00 USD | deriv |
| 30 Nov 2016 | GRANT_AWARD | ACCURAY INC | 23,762 | 0.00 USD |
| 21 Nov 2016 | TAX_WITHHOLDING | ACCURAY INC | 6,818 | 5.30 USD |
| 21 Sept 2016 | GRANT_AWARD | NEKTAR THERAPEUTICS | 8,000 | 0.00 USD |
| 21 Sept 2016 | GRANT_AWARD | NEKTAR THERAPEUTICS | 20,000 | 0.00 USD | deriv |
| 15 Sept 2016 | EXERCISE | NEKTAR THERAPEUTICS | 15,000 | 0.00 USD |
| 15 Sept 2016 | EXERCISE | NEKTAR THERAPEUTICS | 15,000 | 0.00 USD | deriv |
| 15 Jun 2016 | GRANT_AWARD | Pacira BioSciences, Inc. | 1,488 | 0.00 USD |
| 15 Jun 2016 | GRANT_AWARD | Pacira BioSciences, Inc. | 2,975 | 0.00 USD | deriv |